Capricor Therapeutics Inc banner

Capricor Therapeutics Inc
F:4LN2

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
F:4LN2
Watchlist
Price: 24.67 EUR -11% Market Closed
Market Cap: €788.9m

Wall St Price Targets

4LN2 Price Targets Summary
Capricor Therapeutics Inc

Wall Street analysts forecast 4LN2 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4LN2 is 8.34 EUR with a low forecast of 6.5 EUR and a high forecast of 9.9 EUR.

Lowest Forecast
Price Target
6.5 EUR
74% Downside
Average Forecast
Price Target
8.34 EUR
66% Downside
Highest Forecast
Price Target
9.9 EUR
60% Downside
Capricor Therapeutics Inc Competitors:
Price Targets
QNST
Quinstreet Inc
56% Upside
WINA
Winmark Corp
54% Upside
UFPT
UFP Technologies Inc
49% Upside
EXPO
Exponent Inc
48% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 4LN2's stock price target?
Price Target
8.34 EUR

According to Wall Street analysts, the average 1-year price target for 4LN2 is 8.34 EUR with a low forecast of 6.5 EUR and a high forecast of 9.9 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett